Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by valentinemassonon Jun 02, 2020 6:39pm
163 Views
Post# 31103914

RE:Can someone explain the timing of the news?

RE:Can someone explain the timing of the news?Don't think the intention was to screw retail, many offerings are the lowest stock price in the last 30 days, or an average thereof. Given the company is trying to get wind beneath its wings, any institutions up until the overnight offering would more than likely not partake unless they were given a bargain, a ground floor entry if you will. Tripp needs to be transparent, and follow through, time and again to gain credibility. He is an effective speaker, but seems to fizzle out short time later. Respect is earned, not demanded. Bolta. VM
ThunderAcDc wrote: 1. Q4 delayed news.... several, than horrible Q4 which brought the share price down.
2. Q1 delayed news .....

Suddenly as a big surprised, Q1 update news is released 12 days later and 30 days before the date proposed in the Q1 delay.

3. Bad Q1 release for kicking the week which had a immediate reaction to lower more the SP.
4. Few hours later, overnight offering at the lower price seen in more than a month. Last time the stock was at $0.07 was on April the 17th.

Is it me or management worked to screwed retail investor?




Bullboard Posts